Lilly Endowment, Inc. files Form 144 to sell 305,000 LLY shares worth $343.9MLilly Endowment, Inc. 提交 Form 144：拟减持 礼来 (LLY) 305,000 股，约 $343.9M

Planned Sale Details

On June 26, 2026, affiliate shareholder LILLY ENDOWMENT, INC. of Eli Lilly and Company (NYSE: LLY) filed a Form 144 with the U.S. SEC, disclosing a planned sale of 305,000 common shares of the company, with an aggregate market value of approximately $343.9 million as of the filing date. The proposed sale date matches the filing date of June 26, 2026. This disclosure provides market participants with forward-looking insight into potential future equity supply, and must be distinguished from completed share sales.

Formal Planned Sale Parameters

Full details of the filing are available via the official SEC archive link: The seller is an affiliated institutional shareholder of Eli Lilly, and the planned sale represents a large-scale potential equity offering, with total sale value exceeding $300 million. Exact percentage of the float sold will require cross-referencing with latest outstanding share data.

Core Nature of Form 144 Disclosure

Form 144 is a U.S. SEC-mandated notice for affiliates and large shareholders to disclose potential share sale intentions, and does not serve as proof of a completed transaction. The filing does not confirm that the seller has locked in a sale price or finalized the execution of the sale, only fulfilling regulatory requirements for forward-looking disclosure.

Contextual Industry and Company Data

Supporting contextual data includes Eli Lilly’s latest institutional holdings and analyst rating trends: As of December 31, 2025, the company held 4,499 institutional holders, with total institutional holdings valued at $1.6651 trillion, representing 88.2% of the outstanding float, an increase of 466 institutional holders from the prior quarter. As of June 1, 2026, analyst ratings for LLY split as 6 Strong Buy, 18 Buy, 5 Hold, 1 Sell, and 1 Strong Sell, with minimal changes to the rating distribution since May 2026, and only a one-position reduction in Hold ratings since April 2026. This planned sale comes from an affiliated shareholder, and should be separated from routine institutional portfolio adjustments.

Limitations of This Signal and What to Watch Next

1. This filing only outlines a proposed sale plan, and does not confirm that shares have actually been sold;

2. The sale may reflect only the seller’s liquidity needs or asset diversification strategy, and does not directly signal a view on the company’s future performance;

3. This content does not constitute any investment recommendation, and cannot predict short-term or long-term stock price volatility;

4. Market participants should monitor for subsequent Form 4 transaction filings to confirm whether the planned sale is actually executed.